Smith, Gale E <br/><br/>
Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.  [electronic resource] 

 -  Vaccine  Sep 2013 
 - 4305-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2013.07.043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Viral--immunology<br/>Baculoviridae--genetics<br/>Cell Line<br/>Cross Protection--immunology<br/>Hemagglutination Inhibition Tests<br/>Hemagglutinins, Viral--genetics<br/>Influenza A Virus, H7N3 Subtype--immunology<br/>Influenza A Virus, H7N9 Subtype--immunology<br/>Influenza Vaccines--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Neuraminidase--genetics<br/>Orthomyxoviridae Infections--immunology<br/>Spodoptera--genetics<br/>Vaccination<br/>Vaccines, Synthetic--immunology<br/>Viral Matrix Proteins--genetics